EcoDrugPlus

Ensembl ID : ENSCHYG00000003955
Gene Symbol: -
Cross references: -
302 Possible Orthologues:

Ensembl ID : ENSCHYG00000003772
Gene Symbol: -
Cross references: -
71 Possible Orthologues:

Ensembl ID : ENSCHYG00000000647
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSCHYG00000024452
Gene Symbol: -
Cross references: -
289 Possible Orthologues:

Ensembl ID : ENSCHYG00000021904
Gene Symbol: -
Cross references: -
242 Possible Orthologues:

Ensembl ID : ENSCHYG00000021786
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSCHYG00000019943
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSCHYG00000019929
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSCHYG00000019585
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSCHYG00000019268
Gene Symbol: -
Cross references: -
234 Possible Orthologues:

Ensembl ID : ENSCHYG00000013582
Gene Symbol: -
Cross references: -
102 Possible Orthologues:

Ensembl ID : ENSCHYG00000013518
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).